After the first batch of anti-COVID drug 2-DG developed by DRDO was released by Defence Minister Rajnath Singh in New Delhi, it will be available only to AIIMS, Armed Forces Hospitals, DRDO hospitals and other places in need.
While the drug shall be made available to all the hospitals across the country from the first week of June, said DRDO Chairman G Satheesh Reddy.
“The first batch of anti-COVID drug 2-DG will be used in a limited manner. It will be used in AIIMS, Armed Forces Hospitals, DRDO hospitals and any other places where the need arises. From June onwards it will be made available to all hospitals,” said Reddy speaking to reporters.
The DRDO chief further said the production is underway and the second batch of the drug will come around the last week of May. The regular production will take place from June onwards commencing from the first week, he added.
He also mentioned that in the second batch the production span will be increased and from the first week of June it will be made available to all hospitals and other medical facilities in the country.
“This is because the production time and the cycle of this is about a month. After approval from the Drugs Controller General of India (DCGI), the industry is working really hard but it will take a month to reach the normal production capacity,” explained the DRDO chief.
Surjitt Sahani
